Greendale G A, Edelstein S, Barrett-Connor E
Division of Geriatrics, UCLA School of Medicine, USA.
J Bone Miner Res. 1997 Nov;12(11):1833-43. doi: 10.1359/jbmr.1997.12.11.1833.
This study examines the associations between endogenous sex steroids and bone mineral density (BMD), using data from a geographically defined cohort in Rancho Bernardo, California. Participants were community-dwelling women and men aged 50-89 years who took part in a study of endogenous sex steroid measurement between 1984-1987 and who had BMD measured in 1988-1991. Those taking corticosteroids or estrogen at the time of sex steroid determination were excluded. The main study outcomes were BMD of the ultradistal radius, midshaft radius, lumbar spine, and total hip by sex steroid level, adjusted for age, body mass index, cigarette smoking, alcohol consumption, leisure exercise, use of thiazides, thyroid hormones, and former estrogen use (women only). At the time of the hormone measurements, the mean age of the 457 women was 72.1 years and that of the 534 men was 68.6 years. A statistically significant positive relation was seen between bioavailable estradiol and BMD at all sites in women and men. Total estradiol was significantly associated with BMD at all sites in women and at all but the ultradistal radius in men. Estrone had a global effect on BMD in women and was not measured in men. Higher bioavailable (but not total) testosterone levels were associated with higher BMD of the ultradistal radius, spine, and hip in men and the ultradistal radius in women. Dehydroepiandrosterone was positively associated with BMD of the midradius, spine, and hip in women and was not associated with BMD at any site in men. Of the sex steroids tested, bioavailable estrogen was most strongly associated with BMD in both women and men. We conclude that endogenous sex steroid levels are significantly related to bone density in older women and men. Individual variation in age-related bone loss may be partially accounted for by alterations in sex steroid levels with aging. Further study to elucidate safe environmental and medical methods to maintain optimal sex steroid levels in old age is needed.
本研究利用加利福尼亚州兰乔贝纳多一个地理定义队列的数据,考察内源性性激素与骨矿物质密度(BMD)之间的关联。参与者为年龄在50 - 89岁之间的社区居住女性和男性,他们在1984 - 1987年参与了一项内源性性激素测量研究,并于1988 - 1991年测量了骨密度。在性激素测定时正在服用皮质类固醇或雌激素的参与者被排除。主要研究结局是根据性激素水平,对年龄、体重指数、吸烟、饮酒、休闲运动、噻嗪类药物使用、甲状腺激素使用以及既往雌激素使用情况(仅针对女性)进行调整后,按性别划分的尺骨远端、桡骨干、腰椎和全髋部的骨密度。在进行激素测量时,457名女性的平均年龄为72.1岁,534名男性的平均年龄为68.6岁。在女性和男性的所有部位,生物可利用雌二醇与骨密度之间均呈现出具有统计学意义的正相关关系。总雌二醇与女性所有部位的骨密度以及男性除尺骨远端外的所有部位的骨密度均显著相关。雌酮对女性的骨密度具有整体影响,而男性未测量该指标。较高的生物可利用(而非总)睾酮水平与男性尺骨远端、脊柱和髋部以及女性尺骨远端的较高骨密度相关。脱氢表雄酮与女性桡骨中段、脊柱和髋部的骨密度呈正相关,与男性任何部位的骨密度均无关联。在所检测的性激素中,生物可利用雌激素与女性和男性的骨密度关联最为紧密。我们得出结论,内源性性激素水平与老年女性和男性的骨密度显著相关。与年龄相关的骨质流失的个体差异可能部分归因于随着年龄增长性激素水平的变化。需要进一步开展研究,以阐明维持老年期最佳性激素水平的安全环境和医学方法。